Thakur M L, Park C H, Fazio F, Gerundini P, Margonato A, Vicedomini G, Colombo R, Colombo F, Gilardi M, Fregoso F
Int J Appl Radiat Isot. 1984 Jun;35(6):507-15. doi: 10.1016/0020-708x(84)90172-8.
Technetium-99m labeled bis(1,2-diethylphosphino)ethane was evaluated as a cardiac perfusion agent in mice, dogs and normal human volunteers. The agent produced as a single cationic compound was prepared by a simple kit type method and had a rapid myocardial uptake in animals. The cardiac uptake of the agent in dogs averaged 4.6% of administered dose and delineated left and right ventricles by in vivo imaging. In dogs with experimental myocardial infarction, the agent was distributed according to the regional myocardial blood flow, had excellent correlation with myocardial distribution of 85Sr microspheres (r = 0.96, 0.93)] and 201Tl (r = 0.91 and 0.83), and enabled us to detect perfusion defects by in vivo scintigraphy. The agent, however, failed to have a useful degree of cardiac uptake in humans.
对锝-99m标记的双(1,2-二乙基膦基)乙烷在小鼠、狗和正常人类志愿者中作为心脏灌注剂进行了评估。该剂作为单一阳离子化合物通过简单的试剂盒类型方法制备,在动物体内心肌摄取迅速。该剂在狗体内的心脏摄取平均为给药剂量的4.6%,并通过体内成像勾勒出左心室和右心室。在实验性心肌梗死的狗中,该剂根据局部心肌血流分布,与85Sr微球(r = 0.96, 0.93)和201Tl(r = 0.91和0.83)的心肌分布具有良好的相关性,并使我们能够通过体内闪烁显像检测灌注缺损。然而,该剂在人体中未能有足够有用程度的心脏摄取。